66 related articles for article (PubMed ID: 21064110)
1. Risk of invasive cervical cancer in relation to clinical investigation and treatment after abnormal cytology: a population-based case-control study.
Silfverdal L; Kemetli L; Sparén P; Andrae B; Strander B; Ryd W; Dillner J; Törnberg S
Int J Cancer; 2011 Sep; 129(6):1450-8. PubMed ID: 21064110
[TBL] [Abstract][Full Text] [Related]
2. Risk of invasive cervical cancer in relation to management of abnormal Pap smear results.
Silfverdal L; Kemetli L; Andrae B; Sparén P; Ryd W; Dillner J; Strander B; Törnberg S
Am J Obstet Gynecol; 2009 Aug; 201(2):188.e1-7. PubMed ID: 19560117
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
[TBL] [Abstract][Full Text] [Related]
4. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
5. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
6. A study of Pap test history and histologically determined cervical cancer in NSW women, 1997-2003.
Morrell S; Taylor R; Wain G
J Med Screen; 2005; 12(4):190-6. PubMed ID: 16417696
[TBL] [Abstract][Full Text] [Related]
7. [Precancerous cervical lesions during pregnancy: diagnostic and treatment].
Selleret L; Mathevet P
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S131-8. PubMed ID: 18191339
[TBL] [Abstract][Full Text] [Related]
8. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
Martin-Hirsch P; Rash B; Martin A; Standaert B
BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
[TBL] [Abstract][Full Text] [Related]
9. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
Rooker D; Baalbergen A; Helmerhorst TJ
Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
[TBL] [Abstract][Full Text] [Related]
10. Is a liquid-based cytology more sensitive than a conventional Pap smear?
Sigurdsson K
Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
[TBL] [Abstract][Full Text] [Related]
11. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
12. Birth outcomes following treatment for precancerous changes to the cervix: a population-based record linkage study.
Reilly R; Paranjothy S; Beer H; Brooks CJ; Fielder HM; Lyons RA
BJOG; 2012 Jan; 119(2):236-44. PubMed ID: 21790951
[TBL] [Abstract][Full Text] [Related]
13. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
14. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
15. Support for down-staging of pregnancy-associated cervical cancer.
Kärrberg C; Rådberg T; Holmberg E; Norström A
Acta Obstet Gynecol Scand; 2015 Jun; 94(6):654-9. PubMed ID: 25845736
[TBL] [Abstract][Full Text] [Related]
16. Isthmic-vaginal smear cytology in the follow-up after radical vaginal trachelectomy for early stage cervical cancer: is it safe?
Lanowska M; Mangler M; Grittner U; Akbar GR; Speiser D; von Tucher E; Köhler C; Schneider A; Kühn W
Cancer Cytopathol; 2014 May; 122(5):349-58. PubMed ID: 24478265
[TBL] [Abstract][Full Text] [Related]
17. Cervical intraepithelial neoplasia in adolescent women: incidence and treatment outcomes.
Case AS; Rocconi RP; Straughn JM; Wang W; Roark K; Waltman EE; Huh WK
Obstet Gynecol; 2006 Dec; 108(6):1369-74. PubMed ID: 17138768
[TBL] [Abstract][Full Text] [Related]
18. The role of cervical cytology and colposcopy in detecting cervical glandular neoplasia.
Ullal A; Roberts M; Bulmer JN; Mathers ME; Wadehra V
Cytopathology; 2009 Dec; 20(6):359-66. PubMed ID: 18557985
[TBL] [Abstract][Full Text] [Related]
19. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
20. Abnormal cervical cytology following large loop excision of the transformation zone: a case controlled study.
Shafi MI; Dunn JA; Buxton EJ; Finn CB; Jordan JA; Luesley DM
Br J Obstet Gynaecol; 1993 Feb; 100(2):145-8. PubMed ID: 8476806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
